Company type
Industry
Technologies Abzu use
Known addresses in Denmark
Description
Abzu specializes in disease understanding and drug design using its AI technology, the QLattice®. Founded in 2018, the company collaborates with pharmaceutical, biotech, and research sectors to enhance data-driven R&D. Based in Copenhagen and Barcelona, Abzu has raised €13.3M in funding and has been recognized by Gartner and the Nordic Startup Awards.